Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Leprosy.

Warwick J Britton1, Diana N J Lockwood

  • 1Centenary Institute of Cancer Medicine and Cell Biology and Department of Medicine, University of Sydney, NSW 2006, Australia. wbritton@med.usyd.edu.au

Lancet (London, England)
|April 15, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeted delivery of the BCG vaccine to dendritic cells improves protective efficacy against Mycobacterium tuberculosis.

Vaccine·2026
Same author

Descriptions of the natural history of erythema nodosum leprosum to inform clinical classification - A semi-systematic review.

PLoS neglected tropical diseases·2026
Same author

ClpC1-targeting peptide natural products differentially dysregulate the proteome of Mycobacterium tuberculosis.

Nature communications·2026
Same author

Efficacy of Inhalable Endolysin Cpl-1 Formulations in Combination with Gentamicin or Endolysin Pal in a Murine Lung Infection Model.

Pharmaceutical research·2026
Same author

ClpC1 Modulating Ohmyungsamycin A and Ecumicin Natural Product Analogues are Potent Antimycobacterials.

ACS infectious diseases·2025
Same author

Tissue-wide profiling of human lungs reveals spatial sequestration of macrophages in tuberculosis.

bioRxiv : the preprint server for biology·2025
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
Same journal

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Lancet (London, England)·2026
Same journal

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

Lancet (London, England)·2026
See all related articles

Leprosy, a chronic infection by Mycobacterium leprae, causes nerve damage and disabilities. While multi-drug therapy (MDT) reduces prevalence, ongoing control is vital to interrupt transmission.

Area of Science:

  • Infectious Diseases
  • Immunology
  • Dermatology

Background:

  • Leprosy is a chronic granulomatous infection caused by Mycobacterium leprae, affecting skin and peripheral nerves.
  • Disease presentation varies from tuberculoid to lepromatous forms, influenced by the host's cellular immune response.
  • Nerve function impairment leads to the characteristic disabilities associated with leprosy.

Purpose of the Study:

  • To review recent advancements in leprosy biology and clinical understanding.
  • To summarize current diagnostic criteria and emerging treatment strategies for infection and complications.
  • To highlight the impact of multi-drug therapy (MDT) on leprosy control.

Main Methods:

  • Literature review of recent advances in leprosy research.

Related Experiment Videos

  • Analysis of clinical features, diagnostic criteria, and treatment approaches.
  • Evaluation of the effectiveness of supervised multi-drug therapy (MDT).

    • Main Results:

    • Supervised multi-drug therapy (MDT) is highly effective for all leprosy forms.
    • MDT implementation has decreased leprosy prevalence globally.
    • A reduction in the global case-detection rate has not yet been observed.

    Conclusions:

    • Continued leprosy control efforts are essential for decades to interrupt disease transmission.
    • Understanding leprosy biology and immune responses is key to managing the disease.
    • MDT is a cornerstone of leprosy treatment, but sustained public health initiatives are crucial.